Guggenheim Adjusts Price Target on Biogen to $260 From $246
Biogen (BIIB) has an average rating of overweight and mean price target of $215.86, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $191.38, Change: $-3.00, Percent Change: -1.54%